Brief: Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
07/11/2023 12:35
Nov 7 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS THIRD QUARTER 2023
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO SECOND HALF OF 2025
* SENSEI BIOTHERAPEUTICS-PHASE 1/2 TRIAL OF SNS-101
CONTINUES TO
ENROLL AHEAD OF SCHEDULE, WITH NEW CLINICAL DATA MILESTONES
ANTICIPATED THROUGHOUT 2024
Source text for Eikon: ID:nGNX9jRxJ9
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)